| Product Code: ETC7741255 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Legalized Cannabis Medical Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Legalized Cannabis Medical Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Legalized Cannabis Medical Market - Industry Life Cycle |
3.4 Japan Legalized Cannabis Medical Market - Porter's Five Forces |
3.5 Japan Legalized Cannabis Medical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Legalized Cannabis Medical Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 Japan Legalized Cannabis Medical Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Japan Legalized Cannabis Medical Market Revenues & Volume Share, By Compound, 2021 & 2031F |
4 Japan Legalized Cannabis Medical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of the medical benefits of cannabis |
4.2.2 Growing elderly population in Japan seeking alternative healthcare options |
4.2.3 Supportive government regulations and policies promoting the medical cannabis industry |
4.3 Market Restraints |
4.3.1 Cultural stigma and traditional attitudes towards cannabis use in Japan |
4.3.2 Limited availability of medical professionals trained in cannabis-based treatments |
4.3.3 Strict regulations and licensing requirements for cannabis cultivation and distribution |
5 Japan Legalized Cannabis Medical Market Trends |
6 Japan Legalized Cannabis Medical Market, By Types |
6.1 Japan Legalized Cannabis Medical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Legalized Cannabis Medical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Japan Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Herb, 2021- 2031F |
6.1.4 Japan Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Resin, 2021- 2031F |
6.2 Japan Legalized Cannabis Medical Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Japan Legalized Cannabis Medical Market Revenues & Volume, By Raw, 2021- 2031F |
6.2.3 Japan Legalized Cannabis Medical Market Revenues & Volume, By Processed, 2021- 2031F |
6.3 Japan Legalized Cannabis Medical Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Japan Legalized Cannabis Medical Market Revenues & Volume, By Recreational, 2021- 2031F |
6.3.3 Japan Legalized Cannabis Medical Market Revenues & Volume, By Medicinal, 2021- 2031F |
6.4 Japan Legalized Cannabis Medical Market, By Compound |
6.4.1 Overview and Analysis |
6.4.2 Japan Legalized Cannabis Medical Market Revenues & Volume, By THC-Dominant, 2021- 2031F |
6.4.3 Japan Legalized Cannabis Medical Market Revenues & Volume, By CBD-Dominant, 2021- 2031F |
6.4.4 Japan Legalized Cannabis Medical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
7 Japan Legalized Cannabis Medical Market Import-Export Trade Statistics |
7.1 Japan Legalized Cannabis Medical Market Export to Major Countries |
7.2 Japan Legalized Cannabis Medical Market Imports from Major Countries |
8 Japan Legalized Cannabis Medical Market Key Performance Indicators |
8.1 Number of medical facilities offering cannabis-based treatments |
8.2 Research and development investments in cannabis pharmaceuticals |
8.3 Patient enrollment in medical cannabis programs |
8.4 Number of medical professionals trained in cannabis medicine |
8.5 Regulatory changes and updates impacting the medical cannabis market in Japan |
9 Japan Legalized Cannabis Medical Market - Opportunity Assessment |
9.1 Japan Legalized Cannabis Medical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Legalized Cannabis Medical Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 Japan Legalized Cannabis Medical Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 Japan Legalized Cannabis Medical Market Opportunity Assessment, By Compound, 2021 & 2031F |
10 Japan Legalized Cannabis Medical Market - Competitive Landscape |
10.1 Japan Legalized Cannabis Medical Market Revenue Share, By Companies, 2024 |
10.2 Japan Legalized Cannabis Medical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here